
|Articles|June 1, 2008
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
Suzanne Delaney, AstraZeneca
S
Advertisement
ONE TO WATCH:
Suzanne Delaney, ED, Brand Leader, Breast/Prostate, AstraZeneca
An AZ vet, Delaney directs strategy for four of the drug giant's oncology brands, including Armidex, with over $1.25 billion in global sales last year. She won plaudits from her early days carrying the bag, but once she began managing people, her career really took flight. Her model of leadership is based on authenticity. "I don't think age equates in any way to great leadership," she says.
Articles in this issue
almost 18 years ago
Mary Szela, Abbottalmost 18 years ago
Mightier Than the Swordalmost 18 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsalmost 18 years ago
Eric Floyd, Cephalonalmost 18 years ago
Nancy Phelan, Wyethalmost 18 years ago
Tightening the Chainalmost 18 years ago
Kurt Graves, Vertexalmost 18 years ago
Wendy Niebler, Shirealmost 18 years ago
Perfectly ImperfectAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




